Related Experiment Video
Updated: Jun 4, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Gene expression profile and mutational analysis of DNA mismatch repair genes in carcinoma prostate in Indian
Abha Soni1, Anju Bansal, L C Singh
1Institute of Pathology, Indian Council of Medical Research, Tumour Biology, New Delhi, India.
Abstract:
DNA mismatch repair (MMR) plays a role in promoting genetic stability by repairing DNA replication errors, inhibiting recombination between nonidentical DNA sequences, and participating in responses to DNA damage. Although the role of MMR in prostate carcinogenesis remains unclear, MMR deficiency in Carcinoma Prostate (Pca) could prove to be clinically significant. Thus, the present study investigated the gene expression profile of six major MMR genes, viz. hMLH1, hMSH2, hPMS1, hPMS2, hMSH3, and hMSH6, and polymorphism in hMLH1 and hMSH2 in Pca in Indian population. Further, correlation with clinicopathological parameters was evaluated to establish their role as a potential prognostic marker. A significant downregulation of hMLH1, hMSH2, and hPMS2 expression was observed in Pca compared to benign prostatic hyperplasia (BPH). A greater loss of hPMS2 protein in poorly differentiated tumors was demonstrated, which was in concordance with a significant inverse correlation of hPMS2 gene expression with the Gleason score indicating its significance as a marker for Pca progression. An important association of hMLH1-93G>A polymorphism with the risk of Pca was also identified. The results of the present study suggest that an altered MMR has important biological and clinical significance in Pca in Indian population.
Insights
DNA mismatch repair (MMR) gene expression is altered in prostate cancer (Pca). MMR deficiency, particularly hPMS2 loss, correlates with Pca progression and poorer differentiation, suggesting its role as a prognostic marker.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- DNA mismatch repair (MMR) is crucial for maintaining genetic stability.
- The role of MMR in prostate carcinogenesis is not fully understood.
- MMR deficiency may have clinical significance in prostate cancer (Pca).
Purpose of the Study:
- To investigate the gene expression of six key MMR genes in Pca.
- To analyze polymorphisms in hMLH1 and hMSH2 in the Indian population.
- To correlate MMR alterations with clinicopathological parameters as potential prognostic markers.
Main Methods:
- Gene expression profiling of hMLH1, hMSH2, hPMS1, hPMS2, hMSH3, and hMSH6.
- Analysis of hMLH1 and hMSH2 polymorphisms.
- Correlation of MMR status with clinicopathological parameters and Gleason score.
Main Results:
- Significant downregulation of hMLH1, hMSH2, and hPMS2 expression in Pca versus benign prostatic hyperplasia (BPH).
- Loss of hPMS2 protein observed in poorly differentiated tumors.
- Inverse correlation between hPMS2 expression and Gleason score.
- Association of hMLH1-93G>A polymorphism with Pca risk.
Conclusions:
- Altered DNA mismatch repair (MMR) has significant biological and clinical implications in prostate cancer (Pca).
- MMR gene expression and polymorphisms may serve as prognostic markers for Pca progression.
- Further research into MMR's role in Pca pathogenesis is warranted.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mismatch Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
